Tularemia: A Case Series of Patients Diagnosed at the National Reference Center for Rickettsioses From 2008 to 2017.

France Francisella tularensis case series diagnosis tularemia

Journal

Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 19 05 2020
accepted: 17 09 2020
entrez: 19 11 2020
pubmed: 20 11 2020
medline: 20 11 2020
Statut: epublish

Résumé

We describe the epidemiological, clinical, and prognostic aspects of 177 tularemia cases diagnosed at the National Reference Center for rickettsioses, coxiellosis, and bartonelloses between 2008 and 2017. All patients with a microbiological diagnosis of tularemia made in the laboratory were included. Clinical and epidemiological data were collected retrospectively from clinicians in charge of patients using a standardized questionnaire. Diagnostic methods used were indirect immunofluorescence serology, real-time polymerase chain reaction (PCR), and universal PCR targeting the 16S ribosomal ribonucleic acid gene. The series included 54 females and 123 males (sex ratio, 2.28; mean age, 47.38 years). Eighty-nine (50.2%) were confirmed as having tularemia on the basis of a positive Our data suggest that in an endemic area and/or in certain epidemiological contexts, tularemia should be sought to allow an optimized antibiotic therapy and a faster recovery.

Sections du résumé

BACKGROUND BACKGROUND
We describe the epidemiological, clinical, and prognostic aspects of 177 tularemia cases diagnosed at the National Reference Center for rickettsioses, coxiellosis, and bartonelloses between 2008 and 2017.
METHODS METHODS
All patients with a microbiological diagnosis of tularemia made in the laboratory were included. Clinical and epidemiological data were collected retrospectively from clinicians in charge of patients using a standardized questionnaire. Diagnostic methods used were indirect immunofluorescence serology, real-time polymerase chain reaction (PCR), and universal PCR targeting the 16S ribosomal ribonucleic acid gene.
RESULTS RESULTS
The series included 54 females and 123 males (sex ratio, 2.28; mean age, 47.38 years). Eighty-nine (50.2%) were confirmed as having tularemia on the basis of a positive
CONCLUSIONS CONCLUSIONS
Our data suggest that in an endemic area and/or in certain epidemiological contexts, tularemia should be sought to allow an optimized antibiotic therapy and a faster recovery.

Identifiants

pubmed: 33209946
doi: 10.1093/ofid/ofaa440
pii: ofaa440
pmc: PMC7651688
doi:

Types de publication

Journal Article

Langues

eng

Pagination

ofaa440

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Références

Enferm Infecc Microbiol Clin. 2010 Dec;28(10):752-3
pubmed: 20570415
Medicine (Baltimore). 1985 Jul;64(4):251-69
pubmed: 3892222
Emerg Infect Dis. 2010 Feb;16(2):238-43
pubmed: 20113553
Clin Microbiol Rev. 2002 Oct;15(4):631-46
pubmed: 12364373
Infection. 2019 Oct;47(5):683-695
pubmed: 30656604
Open Forum Infect Dis. 2018 Sep 03;5(9):ofy176
pubmed: 30191155
Euro Surveill. 2014 Nov 13;19(45):20956
pubmed: 25411688
Dis Chest. 1958 Dec;34(6):632-9
pubmed: 13597755
Eur J Epidemiol. 2000 Mar;16(3):271-6
pubmed: 10870943
Am J Med. 2013 Oct;126(10):e1
pubmed: 23910519
Emerg Infect Dis. 2002 Jan;8(1):69-73
pubmed: 11749751
Emerg Infect Dis. 2009 Dec;15(12):2049-51
pubmed: 19961699
N Engl J Med. 2001 Nov 29;345(22):1601-6
pubmed: 11757506
APMIS. 2008 Jan;116(1):66-73
pubmed: 18254782
Clin Microbiol Infect. 2008 Dec;14(12):1119-27
pubmed: 19076843
Emerg Infect Dis. 2006 Apr;12(4):678-80
pubmed: 16704820
Int J Infect Dis. 2014 Jan;18:47-51
pubmed: 24239221
J Antimicrob Chemother. 2018 Mar 1;73(3):687-691
pubmed: 29253157
Infection. 2016 Apr;44(2):263-5
pubmed: 26189939
Clin Infect Dis. 2000 Feb;30(2):399-400
pubmed: 10671352
Eur J Clin Microbiol Infect Dis. 2009 Nov;28(11):1363-8
pubmed: 19685089
Infect Dis Clin North Am. 2006 Jun;20(2):289-311, ix
pubmed: 16762740
J Med Case Rep. 2008 Jun 13;2:206
pubmed: 18554395
BMJ Case Rep. 2017 Oct 11;2017:
pubmed: 29025776
Infection. 2009 Dec;37(6):514-21
pubmed: 19826763
Scand J Infect Dis. 2007;39(3):258-61
pubmed: 17366059
Indian J Pathol Microbiol. 2013 Jul-Sep;56(3):252-7
pubmed: 24152503
Emerg Infect Dis. 2008 Dec;14(12):1928-30
pubmed: 19046524
Ann N Y Acad Sci. 2007 Jun;1105:351-77
pubmed: 17442781
Clin Infect Dis. 1999 Dec;29(6):1589-91
pubmed: 10585830
Lancet Infect Dis. 2016 Jan;16(1):113-124
pubmed: 26738841
Infect Dis (Lond). 2017 Feb;49(2):128-131
pubmed: 27564142
J Clin Microbiol. 2019 Jul 26;57(8):
pubmed: 31189580
Scand J Infect Dis. 2007;39(10):880-9
pubmed: 17886125
J Laryngol Otol. 2012 May;126(5):535-7
pubmed: 22401576
Jpn J Infect Dis. 2014;67(4):295-9
pubmed: 25056077
Clin Infect Dis. 2001 Aug 15;33(4):573-6
pubmed: 11462198

Auteurs

Anne Darmon-Curti (A)

Aix Marseille University, Institut de Recherche pour le Developpement (IRD), MEPHI, Institut Hospitalo Universitaire (IHU)-Méditerranée Infection, Marseille, France.

François Darmon (F)

Laboratoire d'Informatique Gaspard-Monge (LIGM), Unité Mixte de Recherche (UMR) 8049, Ecole des Ponts ParisTech, UPE, Marne-la-Vallée, France.

Sophie Edouard (S)

Aix Marseille University, Institut de Recherche pour le Developpement (IRD), MEPHI, Institut Hospitalo Universitaire (IHU)-Méditerranée Infection, Marseille, France.

Aurélie Hennebique (A)

Centre National de Référence des Francisella, Institut de Biologie et de Pathologie, Centre Hospitalier Universitaire Grenoble Alpes, Grenoble, France.
Université Grenoble Alpes, Centre National de la Recherche Scientifique, TIMC-IMAG, Grenoble, France.

Thomas Guimard (T)

Infectious Diseases and Emergency Department, Centre Hospitalier de La Roche sur Yon, La Roche-sur-Yon, France.

Guillaume Martin-Blondel (G)

Service des Maladies Infectieuses et Tropicales, CHU de Toulouse, Toulouse, France.
UMR INSERM/CNRS 1043, Centre de Physiopathologie Toulouse Purpan, Toulouse, France.

Timothée Klopfenstein (T)

Department of Infectious Diseases, Besancon University Hospital, Besançon, France.

Jean-Philippe Talarmin (JP)

Internal Medicine and Infectious Diseases Department, Centre Hospitalier de Cornouaille, Quimper, France.

Didier Raoult (D)

Aix Marseille University, Institut de Recherche pour le Developpement (IRD), MEPHI, Institut Hospitalo Universitaire (IHU)-Méditerranée Infection, Marseille, France.
Centre National de Référence des Rickettsia, Coxiella et Bartonella, IHU-Méditerranée Infection, Marseille, France.

Max Maurin (M)

Centre National de Référence des Francisella, Institut de Biologie et de Pathologie, Centre Hospitalier Universitaire Grenoble Alpes, Grenoble, France.
Université Grenoble Alpes, Centre National de la Recherche Scientifique, TIMC-IMAG, Grenoble, France.

Pierre-Edouard Fournier (PE)

Centre National de Référence des Rickettsia, Coxiella et Bartonella, IHU-Méditerranée Infection, Marseille, France.
Aix Marseille University, IRD, Service de Santé des Armées, VITROME, IHU-Méditerranée Infection, Marseille, France.

Classifications MeSH